 |
|
Special Contribution : Practice guidelines for management of hepatocellular carcinoma 2009
Korean J Hepatol. 2009;15(3):391-423. Published online 2009 Sep 30 DOI: https://doi.org/10.3350/kjhep.2009.15.3.391
|
|
Citations to this article as recorded by
 The relationship between tumor-infiltrating neutrophils and clinical outcomes in patients with resectable hepatocellular carcinoma
Jung Hee Lee, Young Mi Hong
BMC Cancer.2024;[Epub] CrossRef Prognostic difference between surgery and external radiation in patients with stage I liver cancer based on competitive risk model and conditional survival rate
Rong Chen, Yanli An, Muhao Xu, Calogero Casà
PLOS ONE.2024; 19(3): e0298014. CrossRef HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma
Xiaoqing Shi, Jiage Ding, Yanyan Zheng, Jiawei Wang, Navid Sobhani, Praveen Neeli, Gang Wang, Junnian Zheng, Dafei Chai
iScience.2023; 26(3): 106143. CrossRef Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan, Alexandra Crăciun
Diagnostics.2023; 13(5): 816. CrossRef Diagnostic performance of the 2022 KLCA-NCC criteria for hepatocellular carcinoma on magnetic resonance imaging with extracellular contrast and hepatobiliary agents: comparison with the 2018 KLCA-NCC criteria
Ja Kyung Yoon, Sunyoung Lee, Jeong Ah Hwang, Ji Eun Lee, Seung-seob Kim, Myeong-Jin Kim
Journal of Liver Cancer.2023; 23(1): 157. CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Journal of Liver Cancer.2023; 23(1): 1. CrossRef Clinical practice guideline and real-life practice in hepatocellular carcinoma: A Korean perspective
Myung Ji Goh, Dong Hyun Sinn, Jong Man Kim, Min Woo Lee, Dong Ho Hyun, Jeong Il Yu, Jung Yong Hong, Moon Seok Choi
Clinical and Molecular Hepatology.2023; 29(2): 197. CrossRef What should be done to reduce the discrepancy between guidelines and real-life practice for hepatocellular carcinoma in Korea?
Min Kyung Park, Yoon Jun Kim
Clinical and Molecular Hepatology.2023; 29(2): 332. CrossRef Radiotherapy trend in elderly hepatocellular carcinoma: retrospective analysis of patients diagnosed between 2005 and 2017
Bong Kyung Bae, Jeong Il Yu, Hee Chul Park, Myung Ji Goh, Yong-Han Paik
Radiation Oncology Journal.2023; 41(2): 98. CrossRef Current evidence and the potential role of proton beam therapy for hepatocellular carcinoma
Sung Uk Lee, Tae Hyun Kim
Clinical and Molecular Hepatology.2023; 29(4): 958. CrossRef Has the growing evidence of radiotherapy for hepatocellular carcinoma increased the use of radiotherapy in elderly patients?
Tae Hyun Kim
Radiation Oncology Journal.2023; 41(3): 141. CrossRef Incidence and risk factors for development of hepatocellular carcinoma at young age in patients with chronic hepatitis B
Myung Ji Goh, Wonseok Kang, Kwang Min Kim, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2022; 57(1): 70. CrossRef Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts
Sang Il Choi, Yuri Cho, Moran Ki, Bo Hyun Kim, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Eun Kyung Hong, Chang-Min Kim, Joong-Won Park, Hamidreza Karimi-Sari
PLOS ONE.2022; 17(3): e0265668. CrossRef The Significance of Systemic Inflammation Markers in Intrahepatic Recurrence of Early-Stage Hepatocellular Carcinoma after Curative Treatment
Bong Kyung Bae, Hee Chul Park, Gyu Sang Yoo, Moon Seok Choi, Joo Hyun Oh, Jeong Il Yu
Cancers.2022; 14(9): 2081. CrossRef Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017
Bong Kyung Bae, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Dong Hyun Sinn, Moon Seok Choi, Joo Hyun Oh
Frontiers in Oncology.2022;[Epub] CrossRef 2022 KLCA-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2022; 23(12): 1126. CrossRef 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Clinical and Molecular Hepatology.2022; 28(4): 583. CrossRef Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal
Joo Hye Song, Myung Ji Goh, Yewan Park, Joo Hyun Oh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2021; 56(3): 274. CrossRef Prognostic factors of gadoxetic acid–enhanced MRI for postsurgical outcomes in multicentric hepatocellular carcinoma
Seung-seob Kim, Sunyoung Lee, Myeong-Jin Kim
European Radiology.2021; 31(5): 3405. CrossRef Secondarily estimated cure fraction and five-year recurrence-free conditional survival probabilities among patients undergoing surgical resection for hepatocellular carcinoma presenting with minor gross vascular invasion
Byungje Bae, Sung Kyu Song, Eunyoung Choi, Chul-Woon Chung, Yongkeun Park
World Journal of Surgical Oncology.2021;[Epub] CrossRef Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial
Tae Hyun Kim, Young Hwan Koh, Bo Hyun Kim, Min Ju Kim, Ju Hee Lee, Boram Park, Joong-Won Park
Journal of Hepatology.2021; 74(3): 603. CrossRef Diagnostic Performance of KLCA-NCC 2018 Criteria for Hepatocellular Carcinoma Using Magnetic Resonance Imaging: A Systematic Review and Meta-Analysis
Dong Hwan Kim, Bohyun Kim, Seo Yeon Youn, Hokun Kim, Joon-Il Choi
Diagnostics.2021; 11(10): 1763. CrossRef Efficacy of entecavir versus tenofovir in preventing hepatocellular carcinoma in patients with chronic hepatitis B with maintained virologic response
Ji Eun Na, Dong Hyun Sinn, Jeong‐Hoon Lee, Hee Joon Jang, Seon Yeong Baek, Kyung A Kim, Won Seok Kang, Geum‐Youn Gwak, Young‐Han Paik, Yoon Jun Kim, Moon Seok Choi, Jung‐Hwan Yoon, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Journal of Viral Hepatitis.2021; 28(10): 1392. CrossRef Dynamics of liver stiffness-based risk prediction model during antiviral therapy in patients with chronic hepatitis B
Hye Yeon Chon, Yeon Seok Seo, Jung il Lee, Byung Seok Kim, Byoung Kuk Jang, Sang Gyune Kim, Ki Tae Suk, In Hee Kim, Jin-Woo Lee, Young Eun Chon, Moon Young Kim, Soung Won Jeong, Han Ah Lee, Sun Young Yim, Soon Ho Um, Hyun Woong Lee, Kwan Sik Lee, Jeong Eu
European Journal of Gastroenterology & Hepatology.2021; 33(6): 885. CrossRef Risk and Risk Score Performance of Hepatocellular Carcinoma Development in Patients With Hepatitis B Surface Antigen Seroclearance
Yewan Park, Jeong-Hoon Lee, Dong Hyun Sinn, Jun Yong Park, Minseok Albert Kim, Yoon Jun Kim, Jung-Hwan Yoon, Do Young Kim, Sang Hoon Ahn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clinical and Translational Gastroenterology.2021; 12(1): e00290. CrossRef Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
Bao-Jiang Liu, Song Gao, Xu Zhu, Jian-Hai Guo, Xin Zhang, Hui Chen, Xiao-Dong Wang, Ren-Jie Yang
World Journal of Gastrointestinal Oncology.2020; 12(6): 663. CrossRef Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Eun Ju Cho, Seung Up Kim
Gut and Liver.2020; 14(4): 477. CrossRef A phase 2 multicenter study of stereotactic body radiotherapy for hepatocellular carcinoma: Safety and efficacy
Won Il Jang, Sun Hyun Bae, Mi‐Sook Kim, Chul Ju Han, Su Cheol Park, Sang Bum Kim, Eung‐Ho Cho, Chul Won Choi, Kyung Su Kim, Sangyoun Hwang, Jin Ho Kim, A Ram Chang, Younghee Park, Eun Seog Kim, Woo Chul Kim, Sunmi Jo, Hae Jin Park
Cancer.2020; 126(2): 363. CrossRef Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma
Hana Park, Jae Hyung Jung, Min Kyung Jung, Eui-Cheol Shin, Simon Weonsang Ro, Jeon Han Park, Do Young Kim, Jun Yong Park, Kwang-Hyub Han
Hepatology International.2020; 14(2): 249. CrossRef Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Eun Sang Oh, Sang Hee Youn, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Dae Yong Kim
Frontiers in Oncology.2020;[Epub] CrossRef Statin Use and the Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Myung Ji Goh, Dong Hyun Sinn, Seonwoo Kim, Sook Young Woo, Hyun Cho, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Hepatology.2020; 71(6): 2023. CrossRef Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
Jihye Kim, Dong-Hyun Sinn, Moon Seok Choi, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Enzo Tagliazucchi
PLOS ONE.2019; 14(3): e0213547. CrossRef Feasibility of dynamic risk assessment for patients with repeated trans-arterial chemoembolization for hepatocellular carcinoma
Yehyun Park, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jong Eun Yeon, Kwan Soo Byun, Hye Soo Kim, Ji Hoon Kim, Seung Up Kim
BMC Cancer.2019;[Epub] CrossRef Does Risk-Adapted Proton Beam Therapy Have a Role as a Complementary or Alternative Therapeutic Option for Hepatocellular Carcinoma?
Tae Kim, Joong-Won Park, Bo Kim, Hyunjung Kim, Sung Moon, Sang Kim, Sang Woo, Young-Hwan Koh, Woo Lee, Dae Kim, Chang-Min Kim
Cancers.2019; 11(2): 230. CrossRef Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
Shuling Chen, Huilin Jin, Zihao Dai, Mengchao Wei, Han Xiao, Tianhong Su, Bin Li, Xin Liu, Yu Wang, Jiaping Li, Shunli Shen, Qi Zhou, Baogang Peng, Zhenwei Peng, Sui Peng
Cancer Medicine.2019; 8(4): 1530. CrossRef Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini
PLOS ONE.2019; 14(4): e0214613. CrossRef 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2019; 20(7): 1042. CrossRef 2018 Korean Liver Cancer Association–National Cancer Center Korea Practice Guidelines for the Management of Hepatocellular Carcinoma
KLCA Korean Liver Cancer Association, NCC National Cancer Center
Gut and Liver.2019; 13(3): 227. CrossRef Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
Bo Hyun Kim, Joong-Won Park, Jin Sook Kim, Sook-Kyung Lee, Eun Kyung Hong
Gut and Liver.2019; 13(3): 342. CrossRef Paper Alert
Peter Hayes, John Plevris
European Journal of Gastroenterology & Hepatology.2019; 31(10): 1295. CrossRef Non‐invasive tests for liver disease severity and the hepatocellular carcinoma risk in chronic hepatitis B patients with low‐level viremia
Namyoung Paik, Dong H. Sinn, Ji H. Lee, In S. Oh, Jung H. Kim, Wonseok Kang, Geum‐Youn Gwak, Yong‐Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
Liver International.2018; 38(1): 68. CrossRef Novel Albumin–Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization
Jung Hee Kim, Dong Hyun Sinn, Jeong-Hoon Lee, Dongho Hyun, Sung Ki Cho, Sung Wook Shin, Young Chang, Yoon Jun Kim, Jung-Hwan Yoon, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Digestive Diseases and Sciences.2018; 63(4): 1062. CrossRef Reproducibility of European Association for the Study of the Liver criteria and modified Response Evaluation Criteria in Solid Tumors in patients treated with sorafenib
Mi Young Jeon, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Song‐Ee Baek, Hye Soo Kim, Seung Up Kim, Mi Suk Park
Liver International.2018; 38(9): 1655. CrossRef Transarterial chemoembolization extends long-term survival in patients with unresectable hepatocellular carcinoma
Jie-Yu Kong, Shu-Mei Li, Hai-Yan Fan, Lan Zhang, Hui-Jin Zhao, Sheng-Mian Li
Medicine.2018; 97(33): e11872. CrossRef Additional role of liver stiffness measurement in stratifying residual hepatocellular carcinoma risk predicted by serum biomarkers in chronic hepatitis B patients under antiviral therapy
Byeong G. Song, Dong H. Sinn, Sangah Chi, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon S. Choi, Joon H. Lee, Kwang C. Koh, Seung W. Paik
European Journal of Gastroenterology & Hepatology.2018; 30(12): 1447. CrossRef Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
Archana Rastogi
World Journal of Gastroenterology.2018; 24(35): 4000. CrossRef Predictive Value of Procalcitonin for Bacterial Infection after Transarterial Chemoembolization or Radiofrequency Ablation for Hepatocellular Carcinoma
Seung Ji Kang, Uh Jin Kim, Seong Eun Kim, Joon Hwan An, Mi Ok Jang, Dae-Seong Myung, Kyung-Hwa Park, Sook-In Jung, Sung Bum Cho, Hee-Chang Jang, Young Eun Joo
Disease Markers.2018; 2018: 1. CrossRef Treatment for occult hepatocellular carcinoma: does it offer survival advantages over symptom-driven treatment?
Kwang Min Kim, Jiyu Kim, Dong Hyun Sinn, Hye Seung Kim, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Scandinavian Journal of Gastroenterology.2018; 53(6): 727. CrossRef Optimal time of tumour response evaluation and effectiveness of hypofractionated proton beam therapy for inoperable or recurrent hepatocellular carcinoma
Tae Hyun Kim, Joong-Won Park, Bo Hyun Kim, Dae Yong Kim, Sung Ho Moon, Sang Soo Kim, Ju Hee Lee, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Oncotarget.2018; 9(3): 4034. CrossRef Radiotherapeutic strategies for hepatocellular carcinoma with portal vein tumour thrombosis in a hepatitis B endemic area
Jung Ho Im, Sang Min Yoon, Hee Chul Park, Jong Hoon Kim, Jeong Il Yu, Tae Hyun Kim, Jun Won Kim, Taek‐Keun Nam, Kyubo Kim, Hong Seok Jang, Jin Hee Kim, Mi‐Sook Kim, Won Sup Yoon, Inkyung Jung, Jinsil Seong
Liver International.2017; 37(1): 90. CrossRef Risk-adapted simultaneous integrated boost-proton beam therapy (SIB-PBT) for advanced hepatocellular carcinoma with tumour vascular thrombosis
Dae Yong Kim, Joong-Won Park, Tae Hyun Kim, Bo Hyun Kim, Sung Ho Moon, Sang Soo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Chang-Min Kim
Radiotherapy and Oncology.2017; 122(1): 122. CrossRef Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development
Seung Up Kim, Ja Yoon Heo, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn, Hyon‐Suk Kim
Liver International.2017; 37(6): 879. CrossRef Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis
Eui Joo Kim, Jong Eun Yeon, Oh Sang Kwon, Heon Nam Lee, Seung Kak Shin, Seong Hee Kang, Kwan Soo Byun, Jeong Han Kim, So Young Kwon, Sang Jun Suh, Hyung Joon Yim, Yun Soo Kim, Ju Hyun Kim
Digestive Diseases and Sciences.2017; 62(3): 808. CrossRef A quantitative analytical method for PIVKA-II using multiple reaction monitoring-mass spectrometry for early diagnosis of hepatocellular carcinoma
Areum Sohn, Hyunsoo Kim, Su Jong Yu, Jung-Hwan Yoon, Youngsoo Kim
Analytical and Bioanalytical Chemistry.2017; 409(11): 2829. CrossRef Liver Function Assessment Using Albumin–Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
In Soo Oh, Dong Hyun Sinn, Tae Wook Kang, Min Woo Lee, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2017; 62(11): 3235. CrossRef Strategies to tackle the challenges of external beam radiotherapy for liver tumors
Michael I Lock, Jonathan Klein, Hans T Chung, Joseph M Herman, Edward Y Kim, William Small, Nina A Mayr, Simon S Lo
World Journal of Hepatology.2017; 9(14): 645. CrossRef Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
Sang Joon Park, Jae Young Jang, Soung Won Jeong, Young Kyu Cho, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Suyeon Park, Hae In Bang
Medicine.2017; 96(11): e5811. CrossRef Prognostic significance of microvascular invasion in tumor stage for hepatocellular carcinoma
Yong Keun Park, Sung Kyu Song, Bong-Wan Kim, Seung-Keun Park, Chul-Woon Chung, Hee-Jung Wang
World Journal of Surgical Oncology.2017;[Epub] CrossRef Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus‐endemic population
Jonggi Choi, Seungbong Han, Namkug Kim, Young‐Suk Lim
Hepatology.2017; 66(5): 1454. CrossRef Peritumoral decreased uptake area of gadoxetic acid enhanced magnetic resonance imaging and tumor recurrence after surgical resection in hepatocellular carcinoma
Seung Kak Shin, Yun Soo Kim, Young Sup Shim, Seung Joon Choi, So Hyun Park, Dong Hae Jung, Oh Sang Kwon, Duck Joo Choi, Ju Hyun Kim
Medicine.2017; 96(33): e7761. CrossRef A model predicting survival of patients with recurrent or progressive hepatocellular carcinoma: the MORE score
Sang Il Choi, Ami Yu, Bo Hyun Kim, Eun Jeong Ko, Soon Seob Park, Byung‐Ho Nam, Joong‐Won Park
Journal of Gastroenterology and Hepatology.2017; 32(3): 651. CrossRef Barcelona clinic liver cancer-stage C hepatocellular carcinoma
Chung Hwan Jun, Jae Hyun Yoon, Eunae Cho, Sang Soo Shin, Sung Bum Cho, Hee Joon Kim, Chang Hwan Park, Hyun Soon Kim, Sung Kyu Choi, Jong Sun Rew
Medicine.2017; 96(17): e6745. CrossRef Prognostic group stratification and nomogram for predicting overall survival in patients who received radiotherapy for abdominal lymph node metastasis from hepatocellular carcinoma: a multi-institutional retrospective study (KROG 15-02)
Youngkyong Kim, Hee Chul Park, Sang Min Yoon, Tae Hyun Kim, Jieun Lee, Jinhyun Choi, Jeong Il Yu, Jin-Hong Park, Jong Hoon Kim, Joong-Won Park, Jinsil Seong
Oncotarget.2017; 8(55): 94450. CrossRef The management and prognosis of patients with hepatocellular carcinoma: what has changed in 20 years?
Sun Young Yim, Yeon Seok Seo, Chang Ho Jung, Tae Hyung Kim, Jae Min Lee, Eun Sun Kim, Bora Keum, Young Kul Jong, Hyunggin An, Ji Hoon Kim, Hyung Joon Yim, Dong Sik Kim, Yoon Tae Jeen, Jong Eun Yeon, Hong Sik Lee, Hoon Jai Chun, Kwan Soo Byun, Soon Ho Um,
Liver International.2016; 36(3): 445. CrossRef Addition of tumor multiplicity improves the prognostic performance of the hepatoma arterial‐embolization prognostic score
Yehyun Park, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Yong Eun Park, Ji Hye Park, Yong Il Lee, Hae Ryong Yun, Kwang‐Hyub Han
Liver International.2016; 36(1): 100. CrossRef Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas
Eric C. Ehman, Spencer C. Behr, Sarah E. Umetsu, Nicholas Fidelman, Ben M. Yeh, Linda D. Ferrell, Thomas A. Hope
Abdominal Radiology.2016; 41(5): 963. CrossRef Anatomical Resection But Not Surgical Margin Width Influence Survival Following Resection for HCC, A Propensity Score Analysis
Jung‐Woo Lee, Young‐Joo Lee, Kwang‐Min Park, Dae‐Wook Hwang, Jae Hoon Lee, Ki Byung Song
World Journal of Surgery.2016; 40(6): 1429. CrossRef Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis
Tae Yeob Kim, Jae Gon Lee, Joo Hyun Sohn, Ji Yeoun Kim, Sun Min Kim, Jinoo Kim, Woo Kyoung Jeong
Yonsei Medical Journal.2016; 57(1): 138. CrossRef The meaning of gross tumor type in the aspects of cytokeratin 19 expression and resection margin in patients with hepatocellular carcinoma
Sung Chan Gong, Mee‐Yon Cho, Sang Woo Lee, Sung Hoon Kim, Moon Young Kim, Soon Koo Baik
Journal of Gastroenterology and Hepatology.2016; 31(1): 206. CrossRef Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus
Ja Yoon Heo, Seung Up Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Young Nyun Park, Sung Soo Ahn, Kwang-Hyub Han, Hyon-Suk Kim
Medicine.2016; 95(14): e3328. CrossRef Radiotherapy in the multidisciplinary treatment of liver cancer: a survey on behalf of the Italian Association of Radiation Oncology
Francesco Dionisi, Alessia Guarneri, Veronica Dell’Acqua, Mariacristina Leonardi, Rita Niespolo, Gabriella Macchia, Tiziana Comito, Maurizio Amichetti, Pierfrancesco Franco, Savino Cilla, Luciana Caravatta, Filippo Alongi, Giovanna Mantello
La radiologia medica.2016; 121(9): 735. CrossRef Impact of the activity calculation method used in transarterial radioembolization
Ashish K. Jha, Sneha Mithun, Nilendu C. Purandare, Sneha A. Shah, Archi Agrawal, Suyash S. Kulkarni, Nitin Shetty, Venkatesh Rangarajan
Nuclear Medicine Communications.2016; 37(9): 917. CrossRef Primary Prophylaxis for Variceal Bleeding and the Improved Survival of Patients with Newly Diagnosed Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Digestive Diseases and Sciences.2016; 61(11): 3354. CrossRef Imaging prediction of residual hepatocellular carcinoma after locoregional therapy in patients undergoing liver transplantation or partial hepatectomy
Eric C. Ehman, Sarah E. Umetsu, Michael A. Ohliger, Nicholas Fidelman, Linda D. Ferrell, Ben M. Yeh, Judy Yee, Thomas A. Hope
Abdominal Radiology.2016; 41(11): 2161. CrossRef Prediction of the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients after Sustained Virological Response by Aspartate Aminotransferase to Platelet Ratio Index
Keol Lee, Dong Hyun Sinn, Geum-Youn Gwak, Hyun Chin Cho, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(5): 796. CrossRef Factors determining long-term outcomes of hepatocellular carcinoma within the Milan criteria
Jung Hee Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Ki Yeon Kim, Kyunga Kim, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(35): e4735. CrossRef The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?
Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Liver International.2016; 36(10): 1490. CrossRef Usefulness of ascitic fluid lactoferrin levels in patients with liver cirrhosis
Sang Soo Lee, Hyun Ju Min, Ja Yun Choi, Hyun Chin Cho, Jin Joo Kim, Jae Min Lee, Hong Jun Kim, Chang Yoon Ha, Hyun Jin Kim, Tae Hyo Kim, Jin Hyun Kim, Ok-Jae Lee
BMC Gastroenterology.2016;[Epub] CrossRef Case report of The liver transplant patient's cerebral infarction treated with Korean Medicine
Sang Eun Park
Herbal Formula Science.2016; 24(3): 225. CrossRef Lamivudine versus Entecavir for Newly Diagnosed Hepatitis B Virus-Related Hepatocellular Carcinoma
Jung Hee Kim, Dong Hyun Sinn, Kyunga Kim, Hyeseung Kim, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Gut and Liver.2016; 10(6): 939. CrossRef The utility of gadoxetic acid-enhanced magnetic resonance imaging in the surveillance for postoperative recurrence of hepatocellular carcinoma
Jung Hee Kim, Yang Won Min, Geum-Youn Gwak, Yong Han Paik, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik
Medicine.2016; 95(51): e5666. CrossRef Higher Ratio of Serum Alpha-Fetoprotein Could Predict Outcomes in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma and Normal Alanine Aminotransferase
Young-Il Kim, Hyoung Sang Kim, Joong-Won Park, Motoyuki Otsuka
PLOS ONE.2016; 11(6): e0157299. CrossRef Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma
Pei-Pei Song
World Journal of Gastroenterology.2016; 22(1): 262. CrossRef The effect of radiotherapy in liver-confined but non-resectable Barcelona Clinic Liver Cancer stage C large hepatocellular carcinoma
Hong In Yoon, Inkyung Jung, Kwang-Hyub Han, Jinsil Seong
Oncotarget.2016; 7(38): 62715. CrossRef The combination of transcatheter arterial chemoembolization and sorafenib is well tolerated and effective in Asian patients with hepatocellular carcinoma: Final results of the START trial
Yee Chao, Young‐Hwa Chung, Guohong Han, Jung‐Hwan Yoon, Jijin Yang, Jianhua Wang, Guo‐Liang Shao, Byung Ik Kim, Teng‐Yu Lee
International Journal of Cancer.2015; 136(6): 1458. CrossRef Prevalence, Risk Factors and Clinical Characteristics in Patients with Genotype 6 Chronic Hepatitis C: A Single Institute Experience
Seung Kak Shin, Soo Yong Park, Young Kul Jung, Eui Joo Kim, Heon Nam Lee, Jong Joon Lee, Oh Sang Kwon, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
The Korean Journal of Gastroenterology.2015; 65(2): 105. CrossRef Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy
Jung Gil Park
Clinical and Molecular Hepatology.2015; 21(3): 287. CrossRef Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Joong‐Won Park, Minshan Chen, Massimo Colombo, Lewis R. Roberts, Myron Schwartz, Pei‐Jer Chen, Masatoshi Kudo, Philip Johnson, Samuel Wagner, Lucinda S. Orsini, Morris Sherman
Liver International.2015; 35(9): 2155. CrossRef Hepatocellular carcinoma risk in chronic hepatitis B virus–infected compensated cirrhosis patients with low viral load
Dong Hyun Sinn, Junggyu Lee, Juna Goo, Kyunga Kim, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Hepatology.2015; 62(3): 694. CrossRef Normal liver sparing by proton beam therapy for hepatocellular carcinoma: Comparison with helical intensity modulated radiotherapy and volumetric modulated arc therapy
Ja Young Kim, Young Kyung Lim, Tae Hyun Kim, Kwang Hyun Cho, Sang Hyoun Choi, Hojin Jeong, Dae Woong Kim, Jung Hoon Park, Dong Ho Shin, Se Byeong Lee, Sang Soo Kim, Joo-Young Kim, Dae Yong Kim, Joong-Won Park
Acta Oncologica.2015; 54(10): 1827. CrossRef Short Term Virologic Efficacies of Telbivudine versus Entecavir against Hepatitis B-Related Hepatocellular Carcinoma
Young Woon Kim, Jung Hyun Kwon, Eun Chung, Sung Won Lee, Jong-yul Lee, Jeong Won Jang, Kyu Won Chung, Soon Woo Nam
Gastroenterology Research and Practice.2015; 2015: 1. CrossRef Reappraisal of serum alpha‐foetoprotein as a surveillance test for hepatocellular carcinoma during entecavir treatment
Gi‐Ae Kim, Chang Hyeon Seock, Jang Won Park, Jihyun An, Kwang‐Sun Lee, Jee Eun Yang, Young‐Suk Lim, Kang Mo Kim, Ju Hyun Shim, Danbi Lee, Han Chu Lee
Liver International.2015; 35(1): 232. CrossRef Incidental Microscopic Bile Duct Tumor Thrombi in Hepatocellular Carcinoma after Curative Hepatectomy
Jong M. Kim, Choon H. D. Kwon, Jae-Won Joh, Dong H. Sinn, Jae B. Park, Joon H. Lee, Sung J. Kim, Seung W. Paik, Cheol K. Park, Byung C. Yoo
Medicine.2015; 94(6): e450. CrossRef The Korean guideline for hepatocellular carcinoma surveillance
Do Young Kim, Hyun Jung Kim, Seung Eun Jeong, Sang Gyune Kim, Hyung Joon Kim, Dong Hyun Sinn, Yong Joo Lee, Woo Kyoung Jeong, Kui Son Choi, Nae-Yun Heo, Dong Joon Kim, Young Seok Kim, Yong Bum Kim, Yoon Jun Kim, Hyoung-Ryoul Kim, Minseon Park, Chan Wha Le
Journal of the Korean Medical Association.2015; 58(5): 385. CrossRef Image-guided Treatment in the Hepatobiliary System: Role of Imaging in Treatment Planning and Posttreatment Evaluation
Surabhi Bajpai, Avinash Kambadakone, Alexander R. Guimaraes, Ronald S. Arellano, Debra A. Gervais, Dushyant Sahani
RadioGraphics.2015; 35(5): 1393. CrossRef Clinical outcomes of patients with advanced hepatocellular carcinoma treated with sorafenib: a retrospective study of routine clinical practice in multi-institutions
Sae Hwan Lee, Il Han Song, Ran Noh, Ha Yan Kang, Suk Bae Kim, Soon Young Ko, Eoum Seok Lee, Seok Hyun Kim, Byung Seok Lee, An Na Kim, Hee Bok Chae, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Jae Dong Lee, Heon Young Lee
BMC Cancer.2015;[Epub] CrossRef 2014 Korean Liver Cancer Study Group-National Cancer Center Korea Practice Guideline for the Management of Hepatocellular Carcinoma
Korean Journal of Radiology.2015; 16(3): 465. CrossRef The prognosis in cases of hepatocellular carcinoma after hepatectomy: young patients versus older patients
Ji Soo Lee, Jong Man Kim, Seunghwan Lee, Jin-Yong Choi, Wontae Cho, Gyu-Seoung Choi, Jae Berm Park, Choon Hyuck David Kwon, Sung Joo Kim, Jae-Won Joh
Korean Journal of Hepato-Biliary-Pancreatic Surgery.2015; 19(4): 154. CrossRef Liver stiffness‐based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis
Seung Hwan Shin, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang‐Hyub Han, Beom Kyung Kim
Liver International.2015; 35(3): 1054. CrossRef Prognostic indicators for radiotherapy of abdominal lymph node metastases from hepatocellular carcinoma
Doo Yeul Lee, Joong-Won Park, Tae Hyun Kim, Ju Hee Lee, Bo Hyun Kim, Sang Myung Woo, Sang Soo Kim, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2015; 191(11): 835. CrossRef Hepatocellular Carcinoma Risk of Compensated Cirrhosis Patients with Elevated HBV DNA Levels according to Serum Aminotransferase Levels
Junggyu Lee, Dong Hyun Sinn, Jung Hee Kim, Geum-Youn Gwak, Hye Seung Kim, Sin-Ho Jung, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Byung Chul Yoo, Seung Woon Paik
Journal of Korean Medical Science.2015; 30(11): 1618. CrossRef A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song, Myeong Jun Song, Si Hyun Bae, Woo Jin Chung, Jae Young Jang, Young Seok Kim, Sae Hwan Lee, Jun Yong Park, Hyung Joon Yim, Sung Bum Cho, Soo Young Park, Jin Mo Yang
Journal of Gastroenterology.2015; 50(4): 445. CrossRef Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
Seungtaek Lim, Jungwoo Han, Gun Min Kim, Kwang‐Hyub Han, Hye Jin Choi
Journal of Gastroenterology and Hepatology.2015; 30(6): 1024. CrossRef Korean Version of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma (K-MESIAH)
Byung-Ho Nam, Joong-Won Park, Sook-Hyang Jeong, Sang Soo Lee, Ami Yu, Bo Hyun Kim, W. Ray Kim, Sheng-Nan Lu
PLOS ONE.2015; 10(10): e0138374. CrossRef Different Survival of Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma Patients by the Extent of Portal Vein Invasion and the Type of Extrahepatic Spread
Dong Hyun Sinn, Ju-Yeon Cho, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Sheng-Nan Lu
PLOS ONE.2015; 10(4): e0124434. CrossRef Current management of hepatocellular carcinoma: An Eastern perspective
Hyung Joon Yim
World Journal of Gastroenterology.2015; 21(13): 3826. CrossRef SLC15A2 genomic variation is associated with the extraordinary response of sorafenib treatment: whole-genome analysis in patients with hepatocellular carcinoma
Yeon-Su Lee, Bo Hyun Kim, Byung Chul Kim, Aesun Shin, Jin Sook Kim, Seung-Hyun Hong, Jung-Ah Hwang, Jung Ahn Lee, Seungyoon Nam, Sung Hoon Lee, Jong Bhak, Joong-Won Park
Oncotarget.2015; 6(18): 16449. CrossRef Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years
Hyun Jung Lee, Jong Eun Yeon, Eileen L. Yoon, Sang Jun Suh, Keunhee Kang, Hae Rim Kim, Seong Hee Kang, Yang Jae Yoo, Jihye Je, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Kwan Soo Byun
Intervirology.2015; 58(1): 14. CrossRef Role of lamivudine with transarterial chemoembolization in the survival of patients with hepatocellular carcinoma
Xiaojing Xu, Peixin Huang, Hui Tian, Yi Chen, Ningling Ge, Wengquing Tang, Biwei Yang, Jinglin Xia
Journal of Gastroenterology and Hepatology.2014; 29(6): 1273. CrossRef Clinical outcomes and prognostic factors of patients with advanced hepatocellular carcinoma treated with sorafenib as first‐line therapy: A Korean multicenter study
Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Soo Young Park, Ja Kyung Kim, Hyun Woong Lee, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Won Young Tak, Young Oh Kweon, Jung Il Lee, Kwan Sik Lee, Hyung Joon Kim, Kwang‐Hyub Han
Journal of Gastroenterology and Hepatology.2014; 29(7): 1463. CrossRef Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young–Suk Lim, Seungbong Han, Nae–Yun Heo, Ju Hyun Shim, Han Chu Lee, Dong Jin Suh
Gastroenterology.2014; 147(1): 152. CrossRef The effectiveness of gadolinium MRI to improve target delineation for radiotherapy in hepatocellular carcinoma: A comparative study of rigid image registration techniques
D.S. Yang, W.S. Yoon, J.A. Lee, N.K. Lee, S. Lee, C.Y. Kim, H.J. Yim, S.H. Lee, H.H. Chung, S.H. Cha
Physica Medica.2014; 30(6): 676. CrossRef Therapeutic benefit of radiotherapy in huge (≥10 cm) unresectable hepatocellular carcinoma
Kyung Hwan Kim, Mi Sun Kim, Jee Suk Chang, Kwang‐Hyub Han, Do Young Kim, Jinsil Seong
Liver International.2014; 34(5): 784. CrossRef Clinical Features of Non-alcoholic Fatty Liver Disease in Cryptogenic Hepatocellular Carcinoma
Min Young Rim, Oh Sang Kwon, Minsu Ha, Ju Seung Kim, Kwang Il Ko, Dong Kyu Kim, Pil Kyu Jang, Jung Yoon Han, Pyung Hwa Park, Young Kul Jung, Duck Joo Choi, Yun Soo Kim, Ju Hyun Kim
The Korean Journal of Gastroenterology.2014; 63(5): 292. CrossRef Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver
Jong Man Kim, Choon Hyuck David Kwon, Jae-Won Joh, Jae Berm Park, Joon Hyeok Lee, Sung Joo Kim, Seung Woon Paik, Cheol Keun Park, Byung Chul Yoo
Journal of Surgical Oncology.2014; 110(8): 976. CrossRef The feasibility of combined transcatheter arterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma
Ju‐Yeon Cho, Yong‐Han Paik, Hee Chul Park, Jeong Il Yu, Won Sohn, Geum‐Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Liver International.2014; 34(5): 795. CrossRef Long‐term survival after surgical resection for huge hepatocellular carcinoma: Comparison with transarterial chemoembolization after propensity score matching
Yang Won Min, Jun Hee Lee, Geum‐Youn Gwak, Yong Han Paik, Joon Hyoek Lee, Poong‐Lyul Rhee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Moon Seok Choi
Journal of Gastroenterology and Hepatology.2014; 29(5): 1043. CrossRef Long‐term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea
Yoon Hea Park, Beom Kyung Kim, Ja Kyung Kim, Hyeon Chang Kim, Do Young Kim, Jun Yong Park, Kwang‐Hyub Han, Seung Up Kim, Seung Hwan Shin, Kyu Yeon Hahn, Sang Hoon Ahn
Journal of Gastroenterology and Hepatology.2014; 29(5): 1005. CrossRef Oral antiviral therapy improves the diagnostic accuracy of alpha‐fetoprotein levels in patients with chronic hepatitis B
Jae‐Jun Shim, Jung Wook Kim, Chang Kyun Lee, Jae Young Jang, Byung‐Ho Kim
Journal of Gastroenterology and Hepatology.2014; 29(9): 1699. CrossRef Effective Biliary Drainage and Proper Treatment Improve Outcomes of Hepatocellular Carcinoma with Obstructive Jaundice
Yang-Gun Suh, Do Young Kim, Kwang-Hyub Han, Jinsil Seong
Gut and Liver.2014; 8(5): 526. CrossRef A comparison between surgical resection and radiofrequency ablation in the treatment of hepatocellular carcinoma
Eun Kyu Park, Hee Joon Kim, Choong Young Kim, Young Hoe Hur, Yang Seok Koh, Jung Chul Kim, Hyun Jong Kim, Jin Woong Kim, Chol Kyoon Cho
Annals of Surgical Treatment and Research.2014; 87(2): 72. CrossRef Development of Hong Kong Liver Cancer Staging System With Treatment Stratification for Patients With Hepatocellular Carcinoma
Thomas Yau, Vikki Y.F. Tang, Tzy-Jyun Yao, Sheung-Tat Fan, Chung-Mau Lo, Ronnie T.P. Poon
Gastroenterology.2014; 146(7): 1691. CrossRef Long‐term outcomes of second treatment after initial transarterial chemoembolization in patients with hepatocellular carcinoma
Young‐Il Kim, Joong‐Won Park, Hee‐Won Kwak, Bo Hyun Kim, Ju Hee Lee, In Joon Lee, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Chang‐Min Kim
Liver International.2014; 34(8): 1278. CrossRef Comparison of Malnutrition Risk between Patients with Liver Cirrhosis and Viral Hepatitis Carrier: A Single Center Study
Joo Ah Lee, Tae Hee Lee, Ji Yeong Kim, Min Gyu Seok, Min Gyu Kang, Ji Hyun Jeong, Hoon Sup Koo, Kyung Ho Song, Yong Seok Kim, Sun Moon Kim, Kyu Chan Huh, Young Woo Choi, Young Woo Kang
The Korean Journal of Gastroenterology.2014; 64(5): 284. CrossRef Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinoma
Sang Won Kim, Dongryul Oh, Hee Chul Park, Do Hoon Lim, Sung Wook Shin, Sung Ki Cho, Geum-Youn Gwak, Moon Seok Choi, Yong Han Paik, Seung Woon Paik
Radiation Oncology Journal.2014; 32(1): 14. CrossRef Hepatic Arterial Phase on Gadoxetic Acid-Enhanced Liver MR Imaging: A Randomized Comparison of 0.5 mL/s and 1 mL/s Injection Rates
Sung Mo Kim, Suk Hee Heo, Jin Woong Kim, Hyo Soon Lim, Sang Soo Shin, Yong Yeon Jeong, Heoung Keun Kang
Korean Journal of Radiology.2014; 15(5): 605. CrossRef Added Value of Diffusion-Weighted MRI for Evaluating Viable Tumor of Hepatocellular Carcinomas Treated With Radiotherapy in Patients With Chronic Liver Disease
Hyun Jeong Park, Seong Hyun Kim, Kyung Mi Jang, Sanghyeok Lim, Tae Wook Kang, Hee Chul Park, Dongil Choi
American Journal of Roentgenology.2014; 202(1): 92. CrossRef Simultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinoma
Tae Hyun Kim, Joong-Won Park, Yeon-Joo Kim, Bo Hyun Kim, Sang Myung Woo, Sung Ho Moon, Sang Soo Kim, Woo Jin Lee, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2014; 190(10): 882. CrossRef Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus‐endemic area
Hee‐Won Kwak, Joong‐Won Park, Byung‐Ho Nam, Ami Yu, Sang Myung Woo, Tae Hyun Kim, Seong Hoon Kim, Young Hwan Koh, Hyun Beom Kim, Sang Jae Park, Woo Jin Lee, Eun Kyung Hong, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2014; 29(4): 820. CrossRef The Use of Proton Therapy in the Treatment of Gastrointestinal Cancers
Francesco Dionisi, Edgar Ben-Josef
The Cancer Journal.2014; 20(6): 371. CrossRef Time of hepatocellular carcinoma recurrence after liver resection and alpha-fetoprotein Are important prognostic factors for salvage liver transplantation
Sanghoon Lee, Choon Hyuck David Kwon, Jong Man Kim, Jae-Won Joh, Seung Woon Paik, Bong-Wan Kim, Hee-Jung Wang, Kwang-Woong Lee, Kyung-Suk Suh, Suk-Koo Lee
Liver Transplantation.2014; 20(9): 1057. CrossRef Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
Won Sohn, Moon Seok Choi, Ju Yeon Cho, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Gut and Liver.2014; 8(5): 543. CrossRef Comparison of Clinical Manifestations and Outcomes between Hepatitis B Virus- and Hepatitis C Virus-Related Hepatocellular Carcinoma: Analysis of a Nationwide Cohort
Dong Hyun Sinn, Geum-Youn Gwak, Juhee Cho, Seung Woon Paik, Byung Chul Yoo, Pierre Roques
PLoS ONE.2014; 9(11): e112184. CrossRef Effectiveness and safety of proton beam therapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Sung Uk Lee, Joong-Won Park, Tae Hyun Kim, Yeon-Joo Kim, Sang Myung Woo, Young-Hwan Koh, Woo Jin Lee, Sang-Jae Park, Dae Yong Kim, Chang-Min Kim
Strahlentherapie und Onkologie.2014; 190(9): 806. CrossRef Multimodality Management for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma
Chihwan Choi, Gi Hong Choi, Tae Hyun Kim, Masatoshi Tanaka, Mao-Bin Meng, Jinsil Seong
Liver Cancer.2014; 3(3-4): 405. CrossRef Multimodality Treatment Involving Radiotherapy for Advanced Liver-Confined Hepatocellular Carcinoma
Hong In Yoon, Jinsil Seong
Oncology.2014; 87(Suppl. 1): 90. CrossRef 2014 KLCSG-NCC Korea Practice Guidelines for the Management of Hepatocellular Carcinoma: HCC Diagnostic Algorithm
Jeong Min Lee, Joong-Won Park, Byung Ihn Choi
Digestive Diseases.2014; 32(6): 764. CrossRef Prognostic Values of Vascular Endothelial Growth Factor and Matrix Metalloproteinase-2 in Hepatocellular Carcinoma after Radiotherapy
Yang-Gun Suh, Eun-Jung Lee, Hyejung Cha, Seung-Hyun Yang, Jinsil Seong
Digestive Diseases.2014; 32(6): 725. CrossRef Multimodality Treatment with Radiotherapy for Huge Hepatocellular Carcinoma
Hee Ji Han, Mi Sun Kim, Jihye Cha, Jin Sub Choi, Kwang Hyub Han, Jinsil Seong
Oncology.2014; 87(Suppl. 1): 82. CrossRef Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas
Eun Suk Park, Do Hoon Kwon, Jun Bum Park, Do Hee Lee, Young Hyun Cho, Jeong Hoon Kim, Chang Jin Kim
Journal of Neurosurgery.2014; 121(Suppl_2): 102. CrossRef Worse outcome of sorafenib therapy associated with ascites and Child‐Pugh score in advanced hepatocellular carcinoma
Hwi Young Kim, Joong‐Won Park, Jungnam Joo, Hyoseok Kim, Sang Myung Woo, Woo Jin Lee, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2013; 28(11): 1756. CrossRef Treatment Outcomes of Helical Intensity-Modulated Radiotherapy for Unresectable Hepatocellular Carcinoma
Moonkyoo Kong, Seong Eon Hong, Woo Suk Choi†, Jinhyun Choi, Youngkyong Kim
Gut and Liver.2013; 7(3): 343. CrossRef Recent developments in radiotherapy for hepatocellular carcinoma
Hee Chul Park
Journal of the Korean Medical Association.2013; 56(11): 983. CrossRef National Cancer Screening Program for Hepatocellular Carcinoma
Jin-Wook Kim
Korean Journal of Medicine.2013; 84(5): 670. CrossRef Risk factors and a predictive model for acute hepatic failure after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma
Yang Won Min, Jeong Kim, Seonwoo Kim, Young Kyung Sung, Jin Hee Lee, Geum‐Youn Gwak, Yong Han Paik, Moon Seok Choi, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo, Joon Hyeok Lee
Liver International.2013; 33(2): 197. CrossRef Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions
Jae Young Jang, Moon Young Kim, Soung Won Jeong, Tae Yeob Kim, Seung Up Kim, Sae Hwan Lee, Ki Tae Suk, Soo Young Park, Hyun Young Woo, Sang Gyune Kim, Jeong Heo, Soon Koo Baik, Hong Soo Kim, Won Young Tak
Clinical and Molecular Hepatology.2013; 19(1): 1. CrossRef Status of Primary Liver Cancer Found through Routine Health Check-up
Changhyun Lee, Jong In Yang, Hee Jin Byun, Jung Mook Kang, Seoungho Choi, Jeong Yoon Yim
Journal of Korean Medical Science.2013; 28(10): 1449. CrossRef Is It Time to Adopt External Beam Radiotherapy in the NCCN Guidelines as a Therapeutic Strategy for Intermediate/Advanced Hepatocellular Carcinoma?
Wei Jiang, Zhao-Chong Zeng
Oncology.2013; 84(s1): 69. CrossRef Factors influencing hepatocellular carcinoma prognosis after hepatectomy: a single-center experience
Sung Keun Park, Young Kul Jung, Dong Hae Chung, Keon Kuk Kim, Yeon Ho Park, Jung Nam Lee, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
The Korean Journal of Internal Medicine.2013; 28(4): 428. CrossRef Prospective comparison of prognostic values of modified Response Evaluation Criteria in Solid Tumours with European Association for the Study of the Liver criteria in hepatocellular carcinoma following chemoembolisation
Beom Kyung Kim, Kyung Ah Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Seung Up Kim, Myeong-Jin Kim
European Journal of Cancer.2013; 49(4): 826. CrossRef Recent advances in hepatic resection and liver transplantation for hepatocellular carcinoma
Shin Hwang
Journal of the Korean Medical Association.2013; 56(11): 956. CrossRef Early on‐treatment change in liver stiffness predicts development of liver‐related events in chronic hepatitis B patients receiving antiviral therapy
Beom K. Kim, Hyun J. Oh, Jun Y. Park, Do Y. Kim, Sang H. Ahn, Kwang H. Han, Yehyun Park, Eun J. Yoo, Young N. Park, Seung U. Kim
Liver International.2013; 33(2): 180. CrossRef The Korean National Liver Cancer Surveillance Program: Experience of a Single Healthcare Center in 2011
Jae-Jun Shim, Hyun Jin Park, Jung-Wook Kim, Eun Jung Hwang, Chang Kyun Lee, Jae Young Jang, Seong Jin Park, Hyun Rim Choi, Byung-Ho Kim
Korean Journal of Medicine.2013; 84(5): 672. CrossRef Recent advance of local ablation for hepatocellular carcinoma
Hyunchul Rhim
Journal of the Korean Medical Association.2013; 56(11): 964. CrossRef Feasibility of Sorafenib Combined with Local Radiotherapy in Advanced Hepatocellular Carcinoma
Jihye Cha, Jinsil Seong, Ik Jae Lee, Jun Won Kim, Kwang-Hyub Han
Yonsei Medical Journal.2013; 54(5): 1178. CrossRef Feasibility and Efficacy of Stereotactic Ablative Radiotherapy for Barcelona Clinic Liver Cancer-C Stage Hepatocellular Carcinoma
Sun Hyun Bae, Mi-Sook Kim, Chul Koo Cho, Kum Bae Kim, Dong Han Lee, Chul Ju Han, Su Cheol Park, Young Han Kim
Journal of Korean Medical Science.2013; 28(2): 213. CrossRef Recent advances in the management of hepatocellular carcinoma
Hee Chul Park
Journal of the Korean Medical Association.2013; 56(11): 946. CrossRef Recent advances in systemic chemotherapy of hepatocellular carcinoma
Bo Hyun Kim, Joong-Won Park
Journal of the Korean Medical Association.2013; 56(11): 993. CrossRef Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma
Sang Soo Lee, Sook-Hyang Jeong, Young-Sang Byoun, Seong Min Chung, Mun Hyuk Seong, Hyung Rae Sohn, Bo-young Min, Eun Sun Jang, Jin-Wook Kim, Guan Jung Park, Yoon Jin Lee, Kyoung Ho Lee, Soyeon Ahn
BMC Cancer.2013;[Epub] CrossRef Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma
Byong Sun Oh, Jeong Won Jang, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung, Seungok Lee
BMC Cancer.2013;[Epub] CrossRef Efficacy of Sorafenib Monotherapy versus Sorafenib-Based Loco-Regional Treatments in Advanced Hepatocellular Carcinoma
Sangheun Lee, Beom Kyung Kim, Seung Up Kim, Yehyun Park, Sooyun Chang, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Chae Yoon Chon, Kwang-Hyub Han, Salomon M Stemmer
PLoS ONE.2013; 8(10): e77240. CrossRef Two‐week schedule of hypofractionated radiotherapy as a local salvage treatment for small hepatocellular carcinoma
Jin‐hong Park, Sang Min Yoon, Young‐Suk Lim, So Yeon Kim, Ju Hyun Shim, Kang Mo Kim, Han Chu Lee, Byungchul Cho, Geumju Park, Jong Hoon Kim
Journal of Gastroenterology and Hepatology.2013; 28(10): 1638. CrossRef Number of Target Lesions for EASL and Modified RECIST to Predict Survivals in Hepatocellular Carcinoma Treated with Chemoembolization
Beom Kyung Kim, Seung Up Kim, Myeong-Jin Kim, Kyung Ah Kim, Do Young Kim, Jun Yong Park, Sang Hoon Ahn, Kwang-Hyub Han, Chae Yoon Chon
Clinical Cancer Research.2013; 19(6): 1503. CrossRef Hepatobiliary Malignancies: Lessons from Asia
Tiffany C.L. Wong, Ronnie T.P. Poon
Digestive Diseases.2013; 31(1): 130. CrossRef Changes of guidelines diagnosing hepatocellular carcinoma during the last ten-year period
Do Seon Song, Si Hyun Bae
Clinical and Molecular Hepatology.2012; 18(3): 258. CrossRef Risk Factors of Cryptogenic Hepatocellular Carcinoma in Patients with Low Body Mass Index or without Metabolic Syndrome
Hwa Young Song, Hyo Keun Lee, June Sung Lee, Jong Yeon Kim, Yun Hyuk Yim, Tae Jun Song, Won Ki Bae, Nam-Hoon Kim, Kyung-Ah Kim
The Korean Journal of Internal Medicine.2012; 27(1): 47. CrossRef Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long‐term clinical outcomes of 1717 treatment‐naïve patients with hepatocellular carcinoma
Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Mi Sung Park, Eun Hye Kim, Jinsil Seong, Do Youn Lee, Kwang‐Hyub Han
Liver International.2012; 32(7): 1120. CrossRef Scheduled Interval Trans-Catheter Arterial Chemoembolization Followed by Radiation Therapy in Patients with Unresectable Hepatocellular Carcinoma
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Cheol Jin Kim, Dongryul Oh, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Kho, Joon Hyuk Lee
Journal of Korean Medical Science.2012; 27(7): 736. CrossRef The Clinical and Laboratory Characteristics of Patients with Chronic Hepatitis B Using Current or Past Antiviral Therapy in Korea: A Multi-Center, Nation-Wide, Cross-Sectional Epidemiologic Study
Moon Seok Choi, Dong Hyun Sinn, Su-A Kim, Yil Seob Lee, Won Choi, Seung Woon Paik
Gut and Liver.2012; 6(2): 241. CrossRef The management of hepatocellular carcinoma around the world: a comparison of guidelines from 2001 to 2011
Peipei Song, Ruoyan G. Tobe, Yoshinori Inagaki, Norihiro Kokudo, Kiyoshi Hasegawa, Yasuhiko Sugawara, Wei Tang
Liver International.2012; 32(7): 1053. CrossRef Salvage Treatment With Hypofractionated Radiotherapy in Patients With Recurrent Small Hepatocellular Carcinoma
Sun Hyun Bae, Hee Chul Park, Do Hoon Lim, Jung Ae Lee, Geum Yeon Gwak, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
International Journal of Radiation Oncology*Biology*Physics.2012; 82(4): e603. CrossRef Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma
Joong-Won Park, Young Hwan Koh, Hyun Beom Kim, Hwi Young Kim, Sangbu An, Joon-Il Choi, Sang Myung Woo, Byung-Ho Nam
Journal of Hepatology.2012; 56(6): 1336. CrossRef Serum interleukin-6 and C-reactive protein as a prognostic indicator in hepatocellular carcinoma
Jeong Won Jang, Byong Sun Oh, Jung Hyun Kwon, Chan Ran You, Kyu Won Chung, Chul Seung Kay, Hyun Suk Jung
Cytokine.2012; 60(3): 686. CrossRef Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: A case–control study
Oh Sang Kwon, Young Kul Jung, Kyoung Suk Bae, Ju Hyun Kim, Sang Gyune Kim, Young Seok Kim, Jung Il Lee, Jin Woo Lee, Yun Soo Kim
Alcohol.2012; 46(6): 537. CrossRef KASL Clinical Practice Guidelines: Management of chronic hepatitis B
Clinical and Molecular Hepatology.2012; 18(2): 109. CrossRef The Optimal Selection of Radiotherapy Treatment for Hepatocellular Carcinoma
Ik Jae Lee, Jinsil Seong
Gut and Liver.2012; 6(2): 139. CrossRef Type and cause of liver disease in Korea: single-center experience, 2005-2010
Sang Soo Lee, Young-Sang Byoun, Sook-Hyang Jeong, Yeo Myung Kim, Ho Gil, Bo-Young Min, Mun Hyuk Seong, Eun Sun Jang, Jin-Wook Kim
Clinical and Molecular Hepatology.2012; 18(3): 309. CrossRef Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
Hwi Young Kim, Joong‐Won Park, Jungnam Joo, Se Jin Jung, Sangbu An, Sang Myung Woo, Hyun Beom Kim, Young Hwan Koh, Woo Jin Lee, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2012; 27(6): 1051. CrossRef Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma
Young Il Kim, Hee Chul Park, Do Hoon Lim, Hyo Jung Park, Sang Won Kang, Su Yeon Park, Jin Sung Kim, Youngyih Han, Seung Woon Paik
Radiation Oncology Journal.2012; 30(4): 189. CrossRef Radiotherapeutic Strategies in the Management of Hepatocellular Carcinoma
Ik Jae Lee, Jinsil Seong
Oncology.2011; 81(s1): 123. CrossRef Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation
Shin Hwang, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Gil-Chun Park, Young-Dong Yu, Pyoung-Jae Park, Young-Il Choi, Kyoung-Won Kim, Young-Suk Lim, Han Chu Lee, Eun-Sil Yu, Sung-Gyu Lee
Journal of Gastrointestinal Surgery.2011; 15(6): 971. CrossRef Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
Hwi Young Kim, Joong‐Won Park, Byung‐Ho Nam, Hyun Keun Kim, Joon‐Il Choi, Tae Hyun Kim, Hyun Beom Kim, Chang‐Min Kim
Journal of Gastroenterology and Hepatology.2011; 26(11): 1612. CrossRef Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area
Eun Ju Cho, Min Sun Kwack, Eun Sun Jang, Su Jong You, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee
Digestion.2011; 84(s1): 17. CrossRef Imaging diagnosis and staging of hepatocellular carcinoma
Jeong Min Lee, Franco Trevisani, Valerie Vilgrain, Christoph Wald
Liver Transplantation.2011; 17(S2): S34. CrossRef Prognostic Index for Portal Vein Tumor Thrombosis in Patients with Hepatocellular Carcinoma Treated with Radiation Therapy
Jeong Il Yu, Hee Chul Park, Do Hoon Lim, Won Park, Byung Chul Yoo, Seung Woon Paik, Kwang Cheol Koh, Joon Hyuk Lee
Journal of Korean Medical Science.2011; 26(8): 1014. CrossRef The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee
The Korean Journal of Hepatology.2011; 17(3): 189. CrossRef Multidisciplinary Management of Nonresectable Hepatocellular Carcinoma
Hee Chul Park, Jinsil Seong, Masatoshi Tanaka, Zhao-Chong Zeng, Ho Yeong Lim, Sheng Guan, Si Hyun Bae, Won Young Tak
Oncology.2011; 81(s1): 134. CrossRef Asian Consensus Workshop Report: Expert Consensus Guideline for the Management of Intermediate and Advanced Hepatocellular Carcinoma in Asia
Kwang-Hyub Han, Masatochi Kudo, Sheng-Long Ye, Jong Young Choi, Roonni Tung-Ping Poon, Jinsil Seong, Joong-Won Park, Takafumi Ichida, Jin Wook Chung, Pierce Chow, Ann-Lii Cheng
Oncology.2011; 81(s1): 158. CrossRef Serum hepatitis B surface antigen levels in the natural history of chronic hepatitis B infection
J. W. Jang, S. H. Yoo, J. H. Kwon, C. R. You, S. Lee, J. H. Lee, K. W. Chung
Alimentary Pharmacology & Therapeutics.2011; 34(11-12): 1337. CrossRef Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Beom Kyung Kim, Sang Hoon Ahn, Jin Sil Seong, Jun Yong Park, Do Young Kim, Ja Kyung Kim, Do Youn Lee, Kwang Hoon Lee, Kwang-Hyub Han
Liver International.2011; 31(3): 369. CrossRef Usefulness of Bremsstrahlung Images after Intra-arterial Y-90 Resin Microphere Radioembolization for Hepatic Tumors
Young Chul Kim, Yun Hwan Kim, Soon Ho Um, Yeon Seok Seo, Eun Kyung Park, Sun Young Oh, You Mie Han, Jae-Gol Choe
Nuclear Medicine and Molecular Imaging.2011; 45(1): 59. CrossRef Radiation Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Seung Gyu Park, Jin Hee Kim, Sang Jun Byun, Ok Bae Kim, Jae Seok Hwang, Young Kee Oh, Tae Jin Choi
The Journal of the Korean Society for Therapeutic Radiology and Oncology.2011; 29(1): 36. CrossRef 18F‐fluorodeoxyglucose uptake on positron emission tomography as a prognostic predictor in locally advanced hepatocellular carcinoma
Beom Kyung Kim, Won Jun Kang, Ja Kyung Kim, Jinsil Seong, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Do Youn Lee, Kwang Hoon Lee, Jong Doo Lee, Kwang‐Hyub Han
Cancer.2011; 117(20): 4779. CrossRef Molecularly Targeted Therapies for Hepatocellular Carcinoma: Sorafenib as a Stepping Stone
Hwi Young Kim, Joong-Won Park
Digestive Diseases.2011; 29(3): 303. CrossRef Treatment Algorithm for Intermediate and Advanced Stage Hepatocellular Carcinoma: Korea
Jong Young Choi
Oncology.2011; 81(s1): 141. CrossRef The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care
Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee
The Korean Journal of Hepatology.2011; 17(3): 189. CrossRef Superior long-term outcomes after surgery in child-pugh class a patients with single small hepatocellular carcinoma compared to radiofrequency ablation
Won Kyoung Yun, Moon Seok Choi, Dongil Choi, Hyun-Chul Rhim, Jae Won Joh, Kyung Hee Kim, Tae Hoon Jang, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
Hepatology International.2011; 5(2): 722. CrossRef Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion
Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, HanLim Moon, Shukui Qin, Sheng-Long Ye, Ee-Min Yeoh, Winnie Yeo
Liver International.2010; 30(10): 1427. CrossRef Liver Cancer Working Group Report
M. Kudo, K. H. Han, N. Kokudo, A.-L. Cheng, B. I. Choi, J. Furuse, N. Izumi, J.-W. Park, R. T. Poon, M. Sakamoto
Japanese Journal of Clinical Oncology.2010; 40(Supplement): i19. CrossRef Effect of alcohol on the development of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis: a cross-sectional case-control study
Oh Sang Kwon, Young Kul Jung, Yun Soo Kim, Sang Gyune Kim, Young Seok Kim, Jung Il Lee, Jin Woo Lee, Young Soo Kim, Byung Chul Chun, Ju Hyun Kim
The Korean Journal of Hepatology.2010; 16(3): 308. CrossRef Hypofractionated Radiotherapy for Small-sized Hepatocellular Carcinoma as Salvage Therapy: Sustained Local Control and Safety
Sun Hyun Bae, Hee Chul Park, Do Hoon Lim, Jung Ae Lee, Moon Seok Choi, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
The Journal of the Korean Society for Therapeutic Radiology and Oncology.2010; 28(2): 85. CrossRef Liver Transplantation for Advanced Hepatocellular Carcinoma
Kwang-Woong Lee, Kyung-Suk Suh
Korean Journal of Transplantation.2010; 24(1): 4. CrossRef Long-term outcome of preoperative transarterial chemoembolization and hepatic resection in patients with hepatocellular carcinoma
Ja Young Kang, Moon Seok Choi, Sue Jin Kim, Jae Sook Kil, Joon Hyoek Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo
The Korean Journal of Hepatology.2010; 16(4): 383. CrossRef Eastern asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma
Winnie Yeo, Pei-Jer Chen, Junji Furuse, Kwang-Hyub Han, Chiun Hsu, Ho-Yeong Lim, Hanlim Moon, Shukui Qin, Ee-Min Yeoh, Sheng-Long Ye
BMC Cancer.2010;[Epub] CrossRef Current status of liver diseases in Korea: Hepatocellular carcinoma
Il Han Song, Kyung Sik Kim
The Korean Journal of Hepatology.2009; 15(Suppl 6): S50. CrossRef
|